secwatch.observer — SEC 8-K summary
======================================

Issuer:     NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC)
CIK:        0001500198
Form:       8-K
Filed at:   2024-05-14T23:59:59+00:00
Accession:  0001213900-24-042938
Event type: earnings
Sentiment:  positive
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NeuroOne Q2 FY2024 product revenue triples to $1.38M; OneRF ablation system launched
--------------------------------------------------------------------------------

- Product revenue $1.38M in Q2 2024, up from $466K in Q2 2023.
- Net loss narrowed to $2.9M vs $3.5M a year ago; six-month net loss $6.2M.
- Cash and cash equivalents $2.4M as of March 31, 2024, down from $5.3M at Sept 30, 2023.
- Initiated limited commercial launch of OneRF Ablation System in late March; 5 patients implanted.
- Zimmer Biomet continued expanding sEEG electrode accounts; raised $2.0M via ATM in Q2.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1500198/000121390024042938/0001213900-24-042938-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1500198/000121390024042938/ea0205728-8k_neuro.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-042938

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer